TGA Approval

EMPLICITI elotuzumab 400mg lyophilized powder for IV infusion vial (260055)

ARTG ID

260055

ARTG Name

EMPLICITI elotuzumab 400mg lyophilized powder for IV infusion vial

Sponsor

Bristol-Myers Squibb Australia Pty Ltd

ARTG Date

September 22, 2016

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

BRISTOL-MYERS SQUIBB AUSTRALIA PTY LTD

https://medical-cdn.nocode.com/drug_tga/8dc318a4c2acc79de89f9be6333b45c4.pdf

https://medical-cdn.nocode.com/drug_tga/58a3b5e6b9a0769ad2ffe8d29331ce7e.pdf

Ingredient Name

elotuzumab

Empowering clinical research with data-driven insights and AI-powered tools.